Gil-Sánchez, A.; Gonzalo, H.; Canudes, M.; Nogueras, L.; González-Mingot, C.; Valcheva, P.; Torres, P.; Serrano, J.C.; Peralta, S.; Solana, M.J.;
et al. Can Glatiramer Acetate Prevent Cognitive Impairment by Modulating Oxidative Stress in Patients with Multiple Sclerosis? Pharmaceuticals 2024, 17, 459.
https://doi.org/10.3390/ph17040459
AMA Style
Gil-Sánchez A, Gonzalo H, Canudes M, Nogueras L, González-Mingot C, Valcheva P, Torres P, Serrano JC, Peralta S, Solana MJ,
et al. Can Glatiramer Acetate Prevent Cognitive Impairment by Modulating Oxidative Stress in Patients with Multiple Sclerosis? Pharmaceuticals. 2024; 17(4):459.
https://doi.org/10.3390/ph17040459
Chicago/Turabian Style
Gil-Sánchez, Anna, Hugo Gonzalo, Marc Canudes, Lara Nogueras, Cristina González-Mingot, Petya Valcheva, Pascual Torres, Jose Carlos Serrano, Silvia Peralta, Maria José Solana,
and et al. 2024. "Can Glatiramer Acetate Prevent Cognitive Impairment by Modulating Oxidative Stress in Patients with Multiple Sclerosis?" Pharmaceuticals 17, no. 4: 459.
https://doi.org/10.3390/ph17040459
APA Style
Gil-Sánchez, A., Gonzalo, H., Canudes, M., Nogueras, L., González-Mingot, C., Valcheva, P., Torres, P., Serrano, J. C., Peralta, S., Solana, M. J., & Brieva, L.
(2024). Can Glatiramer Acetate Prevent Cognitive Impairment by Modulating Oxidative Stress in Patients with Multiple Sclerosis? Pharmaceuticals, 17(4), 459.
https://doi.org/10.3390/ph17040459
